Sandra Lockmer
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Genetic factors in colorectal cancer
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 11
- Oncology 7
- Viral-associated cancers and disorders 5
- Co-authors
- Eva Kimby (11 shared papers)Björn E. Wahlin (8 shared papers)Hans Hagberg (3 shared papers)Bjørn Østenstad (6 shared papers)Martin Erlanson (1 shared paper)O. Lindén (1 shared paper)Herman Nilsson‐Ehle (1 shared paper)Oskar Hagberg (1 shared paper)
- Journals
- Blood (2 papers)British Journal of Haematology (2 papers)HemaSphere (1 paper)Journal of Clinical Oncology (1 paper)Leukemia (1 paper)
- Partner nations
- SwedenNorwayUnited States
In The Last Decade
Sandra Lockmer
12 papers receiving 206 citations
Peers
Comparison fields: 5 of 22
- Pathology and Forensic Medicine 190
- Genetics 80
- Oncology 154
- Reproductive Medicine 46
- Neurology 29
Countries citing papers authored by Sandra Lockmer
This map shows the geographic impact of Sandra Lockmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Lockmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Lockmer more than expected).
Fields of papers citing papers by Sandra Lockmer
This network shows the impact of papers produced by Sandra Lockmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Lockmer. The network helps show where Sandra Lockmer may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Lockmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 95 | |
| 2 | 2019 | 44 | |
| 3 | 2018 | 40 | |
| 4 | 2020 | 12 | |
| 5 | 2023 | 5 | |
| 6 | 2022 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 2 | |
| 9 | 2020 | 2 | |
| 10 | 2018 | 2 | |
| 11 | 2025 | 1 | |
| 12 | 2015 | 1 |
About Sandra Lockmer
Sandra Lockmer is a scholar working on Pathology and Forensic Medicine, Oncology, Genetics, Molecular Biology and Neurology, having authored 12 papers that have together received 209 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (11 papers), Chronic Lymphocytic Leukemia Research (6 papers), Viral-associated cancers and disorders (5 papers), CNS Lymphoma Diagnosis and Treatment (3 papers), RNA modifications and cancer (2 papers), Immune Cell Function and Interaction (1 paper), Protein Degradation and Inhibitors (1 paper) and Immunodeficiency and Autoimmune Disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (190 citations), Genetics (80 citations), Oncology (154 citations), Reproductive Medicine (46 citations) and Neurology (29 citations). Sandra Lockmer has collaborated with scholars based in Sweden, Norway and United States. Frequent co-authors include Eva Kimby, Björn E. Wahlin, Hans Hagberg, Bjørn Østenstad, Martin Erlanson, O. Lindén, Herman Nilsson‐Ehle, Oskar Hagberg, Stefan Peterson and Weicheng Ren. Their work appears in journals such as Blood, British Journal of Haematology, HemaSphere, Journal of Clinical Oncology and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.